These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18214755)

  • 1. Preliminary study on the development of nanoemulsions for carbamazepine intravenous delivery: an investigation of drug polymorphic transition.
    Kelmann RG; Kuminek G; Teixeira HF; Koester LS
    Drug Dev Ind Pharm; 2008 Jan; 34(1):53-8. PubMed ID: 18214755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
    Koester LS; Mayorga P; Pereira VP; Petzhold CL; Bassani VL
    Drug Dev Ind Pharm; 2003 Feb; 29(2):145-54. PubMed ID: 12648011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine.
    Nair R; Kumar AC; Priya VK; Yadav CM; Raju PY
    Lipids Health Dis; 2012 Jun; 11():72. PubMed ID: 22695222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.
    Katzhendler I; Azoury R; Friedman M
    J Control Release; 2000 Apr; 65(3):331-43. PubMed ID: 10699292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process.
    Kelmann RG; Kuminek G; Teixeira HF; Koester LS
    Int J Pharm; 2007 Sep; 342(1-2):231-9. PubMed ID: 17582711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in commercial carbamazepine samples--impact on drug release.
    Flicker F; Eberle VA; Betz G
    Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice.
    Madhusudhan B; Rambhau D; Apte SS; Gopinath D
    J Drug Target; 2007 Feb; 15(2):154-61. PubMed ID: 17365287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of the in vitro release of carbamazepine from tablets.
    Uzunović A; Vranić E; Hadzidedić S
    Bosn J Basic Med Sci; 2010 Aug; 10(3):234-8. PubMed ID: 20846131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients.
    Conceição J; Adeoye O; Cabral-Marques H; Concheiro A; Alvarez-Lorenzo C; Sousa Lobo JM
    AAPS PharmSciTech; 2020 Jan; 21(2):39. PubMed ID: 31897724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoemulsion-based Parenteral Drug Delivery System of Carbamazepine: Preparation, Characterization, Stability Evaluation and Blood-Brain Pharmacokinetics.
    Tan SL; Stanslas J; Basri M; Abedi Karjiban RA; Kirby BP; Sani D; Basri HB
    Curr Drug Deliv; 2015; 12(6):795-804. PubMed ID: 26324229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable carbamazepine colloidal systems using the cosolvent technique.
    Douroumis D; Fahr A
    Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions.
    Kogan A; Popov I; Uvarov V; Cohen S; Aserin A; Garti N
    Langmuir; 2008 Feb; 24(3):722-33. PubMed ID: 18163657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N; Zhang W; Jin Y; Quan DQ
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insight Into Thermodynamical Stability of Carbamazepine.
    Dołęga A; Zieliński PM; Osiecka-Drewniak N
    J Pharm Sci; 2019 Aug; 108(8):2654-2660. PubMed ID: 30926446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced drug dissolution using evaporative precipitation into aqueous solution.
    Sarkari M; Brown J; Chen X; Swinnea S; Williams RO; Johnston KP
    Int J Pharm; 2002 Aug; 243(1-2):17-31. PubMed ID: 12176292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
    Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components.
    Barakat NS; Elbagory IM; Almurshedi AS
    AAPS PharmSciTech; 2008; 9(4):1054-62. PubMed ID: 18843537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.